Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Diabetes Care|March 1, 2003
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trialPriscilla A Hollander, Philip Levy, Mark S Fineman, et al.Diabetes Technology & Therapeutics|May 23, 2002
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetesRobert E Ratner, Laura L Want, Mark S Fineman, et al.Diabetes, Obesity & Metabolism|January 13, 2012
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatmentMark S Fineman, K F Mace, M Diamant, et al.Journal of Vitreoretinal Diseases|February 23, 2026
Outcomes after a Physician-directed Pause of Anti-Vascular Endothelial Growth Factor Therapy in Eyes with Branch Retinal Vein OcclusionBita Momenaei, Joseph R Weintraub, Dawson C Williams, et al.European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritisYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.Ophthalmology|November 1, 2006
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachmentEric D Weichel, Adam Martidis, Mitchell S Fineman, et al.Rheumatology and Therapy|October 30, 2023
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm StudyMark S Fineman, Timothy E McAlindon, Christian Lattermann, et al.Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical responseRichard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Joint Task Force Algorithm and Annotations for Diagnosis and Management of RhinitisM S Dykewicz, S Fineman, R Nicklas, et al.Pageof 9